Piperazine derivatives and their use as synthesis intermediates

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7381821
APP PUB NO 20060183903A1
SERIAL NO

10548709

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to new enantiomerically pure piperazine derivatives of formula (I) wherein Y represents hydroxy or a leaving group and n is 1, 2, 3, 4 or 5, and to their use as synthesis intermediates, especially for the preparation of pharmaceutically active compounds ##STR00001##

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UCB S AALLEE DE LA RECHERCHE 60 BRUSSELS 1070

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ates, Celal Louvain-la-Neuve, BE 10 11
Bouvy, Didier Ottignies, BE 4 19
Cavoy, Emile Ham-sur-Heure, BE 9 42

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation